|
J Biol Chem, Vol. 274, Issue 51, 36796-36800, December 17, 1999
Identification of COUP-TF as a Transcriptional Repressor of
the c-mos Proto-oncogene*
Hong-bo
Lin ,
Marion
Jurk ,
Tod
Gulick§, and
Geoffrey M.
Cooper ¶
From the Department of Biology, Boston University,
Boston, Massachusetts 02215 and the § Diabetes Research
Laboratory and Medical Services, Massachusetts General Hospital,
Charlestown, Massachusetts 02129
 |
ABSTRACT |
The c-mos proto-oncogene is
specifically expressed in the male and female germ cells of the mouse
and other vertebrates. We previously identified a 15-base pair sequence
element (B2) as the binding site of a candidate repressor of
c-mos transcription in somatic cells. In the present study,
we used the yeast one-hybrid system to isolate HeLa cell cDNAs
encoding proteins that specifically bound to the c-mos B2
element. Nucleotide sequencing identified several of the clones
isolated in this screen as the orphan nuclear receptors COUP-TFI and
COUP-TFII. A COUP-TF-binding site was then identified within the B2
sequence. Complexes formed between purified COUP-TFs and the
c-mos B2 probe comigrated in electrophoretic mobility shift
assays with those formed using whole nuclear extracts of NIH 3T3 or
HeLa cells. Moreover, the complexes formed with NIH 3T3 nuclear
extracts and B2 probe were supershifted with antibody against COUP-TF,
identifying COUP-TF as the candidate repressor previously detected in
these somatic cell extracts. Substitution of a consensus
COUP-TF-binding site for the c-mos negative regulatory element suppressed expression from the c-mos promoter in
transfected somatic cells, demonstrating the functional activity of
COUP-TF as a repressor of c-mos transcription.
 |
INTRODUCTION |
The c-mos proto-oncogene, which encodes a
protein-serine/threonine kinase, is unusual in its highly restricted
pattern of tissue-specific expression. In contrast to other
proto-oncogenes, which are generally expressed in a wide range of cell
types, c-mos is specifically expressed in the male and
female germ cells of the mouse and several other species (1-8).
Studies utilizing both microinjection of antisense oligonucleotides and
inactivation of c-mos by homologous recombination have
demonstrated that Mos is required for normal oocyte meiosis, including
progression from meiosis I to meiosis II and maintenance of metaphase
II arrest (9-15). Although a role for Mos in male germ cells remains
to be demonstrated, its specific expression in spermatocytes suggests that Mos may also function in spermatogenesis.
Transcription of c-mos is initiated from different promoters
in murine spermatocytes and oocytes, located approximately 280 and 53 base pairs upstream of the c-mos translation initiation codon, respectively (5, 16). Additional sequences involved in
tissue-specific regulation of c-mos have been identified
within a negative regulatory region, located approximately 100 to 200 nucleotides upstream of the mouse c-mos spermatocyte
promoter, that suppresses c-mos transcription in somatic
cells (17). Deletion of these sequences allows expression of reporter
constructs driven by the c-mos promoter in transfected NIH
3T3 cells and other somatic cell types (17). Further analysis by
site-directed mutagenesis identified three sequence elements
(designated B1, B2, and B3) within this region that functioned to
repress c-mos transcription and that were conserved in the
mouse, rat, and human c-mos genes (17). The c-mos
negative regulatory region was further found to suppress transcription
from a heterologous promoter and to function in cells of human and rat,
as well as mouse, origin (17).
These studies suggested that c-mos transcription in somatic
cells was suppressed by repressors that recognized conserved sequences within the c-mos negative regulatory region. Using
electrophoretic mobility shift assays and UV cross-linking, we
identified a candidate repressor protein that bound to one of the
c-mos negative regulatory elements (B2) (18). Mutations of
the B2 element both abolished protein binding and allowed transcription
from the c-mos promoter in transfected somatic cells. The
candidate repressor was present in nuclear extracts of several mouse
cell lines and somatic tissues, as well as in HeLa cells, consistent
with the general repression of c-mos in somatic cells and
with the activity of the mouse c-mos negative regulatory
sequence in cells of human as well as mouse origin. In contrast,
nuclear extracts of testicular germ cells, in which c-mos is
transcribed, formed a distinct protein complex with the
c-mos negative regulatory sequence. The protein identified by binding to the c-mos B2 element thus appeared to be a
strong candidate for a somatic cell repressor of c-mos transcription.
In the present study, we have used the yeast one-hybrid system (19, 20)
to isolate molecular clones encoding this candidate repressor of
c-mos transcription. Our results identify this
c-mos regulatory protein as COUP-TF, an orphan member of the
nuclear receptor family that has previously been shown to function as a
transcriptional repressor of a variety of target genes (21, 22).
 |
EXPERIMENTAL PROCEDURES |
Yeast One-hybrid System--
A yeast one-hybrid system
(CLONTECH) was used to screen a HeLa cell cDNA
library to identify proteins that bound to the c-mos negative regulatory sequence. A c-mos/HIS3
reporter construct was generated by inserting three tandem repeats of
the c-mos 15-base pair box 2 (B2) negative regulatory
element (CCAAGTTCACTGTAC) (18) in the SacI and
SacII sites of the pHISi integration vector. In this vector,
the HIS3 gene is expressed from a minimal promoter that
allows a low level of HIS3 expression. The yeast strain
YM4271 (his3,leu2) was transformed with the
c-mos/HIS3 construct and transformants were selected for
growth on medium lacking histidine (His medium). A
transformant that grew on His medium but failed to grow
on His medium supplemented with 30 mM
3-amino-1,2,4-triazole
(3-AT),1 added to suppress
growth resulting from low level HIS3 expression from the
minimal promoter, was then isolated and used as the
c-mos/HIS3 reporter strain for library screening.
A hybrid library in which HeLa cell cDNAs were fused to the GAL4
activation domain (CLONTECH) was then screened by
transformation of the reporter strain carrying the
c-mos/HIS3 construct. The library vector also
contained a LEU2 selectable marker, allowing selection of
all transformants on Leu medium and of transformants
expressing hybrid proteins that activated transcription of the
c-mos/HIS3 reporter construct on
Leu /His /3-AT medium.
Preparation of COUP-TFI and TFII--
Native COUP-TFI and
COUP-TFII were overexpressed using recombinant vaccinia viruses in HeLa
cells (23). Each was also overexpressed with amino-terminal
polyhistidyl fusions in BL21 (DE3) bacteria using a derivative of the
pET11 vector. His6-tagged proteins were purified by
nickel-agarose affinity chromatography.
Preparation of Nuclear Extracts--
Nuclear extracts were
prepared from NIH 3T3 and HeLa cells as described previously (18).
Electrophoretic Mobility Shift Assays--
Electrophoretic
mobility shift assays were performed as described (18). Purified
COUP-TFs or nuclear extracts were mixed with 1 µg of poly(dI-dC) in
10 mM HEPES (pH 7.5), 10% glycerol, 1 mM EDTA,
100 mM NaCl and incubated for 15 min at room temperature. Radiolabeled DNA was then added and incubation was continued at room
temperature for another 30 min. Samples were then electrophoresed in
5% polyacrylamide gels and analyzed using a PhosphorImager (Molecular
Dynamics). In competition experiments, the indicated amount of
unlabeled oligonucleotide was added at the same time as the
radiolabeled DNA. For supershift experiments, polyclonal antibody
against COUP-TF (24) (a generous gift of Ming-Jer Tsai, Baylor College
of Medicine) was mixed with nuclear extracts in the presence of
poly(dI-dC) and incubated for 30 min at room temperature prior to
addition of radiolabeled DNA.
Plasmids--
Plasmids containing mouse c-mos
upstream sequences linked to the chloramphenicol acetyltransferase
(CAT) gene were previously described (17). The c-mos/-746
plasmid contains a 731-base pair c-mos fragment ( 16 to
746 with respect to the mouse c-mos ATG) that includes the
negative regulatory sequence. The negative regulatory sequence has been
deleted from the c-mos/ 392 plasmid, which contains sequences from 16 to 392 with respect to the mouse c-mos
ATG. The c-mos/ 380/DR1 plasmid was constructed from
c-mos/ 746 by removing the sequences upstream of the
BclI site at 380 (including the negative regulatory
sequence) and adding a synthetic oligonucleotide containing a single
copy of the consensus COUP-TF binding sequence DR1 (CAGGTCACAGGTCAGA).
Transient Expression Assays--
NIH 3T3 cells (5 × 105 per 60-mm plate) were transfected with 5 µg of CAT
plasmid DNA (CsCl gradient purified) and 15 µg of calf thymus DNA as
carrier using calcium phosphate (17). Cells were harvested 48 h
after transfection and lysed in 100 µl of 0.25 M Tris/HCl
(pH 7.8) by 3 cycles of freezing and thawing. Cell lysates were
clarified by centrifugation and protein concentration was determined
using the Bio-Rad protein assay. Extracts (50 or 100 µg of protein)
were incubated overnight at 37 °C in 0.25 M Tris/HCl (pH
7.8) with acetyl-coenzyme A and [14C]chloramphenicol as
substrates. The conversion of chloramphenicol to acetylated forms was
assayed by thin-layer chromatography and quantified using a
PhosphorImager with ImageQuant software.
 |
RESULTS |
Molecular Cloning of Proteins That Bind to the c-mos Negative
Regulatory Element--
We previously identified a 15-base pair
sequence (termed box 2 or B2) as the binding site of a candidate
repressor of c-mos transcription (18). To identify the
candidate repressor, we used the yeast one-hybrid system (19, 20) to
isolate cDNA clones encoding DNA-binding proteins that specifically
recognized this sequence. The reporter construct used in this screen
consisted of three concatamerized copies of the 15-base pair
c-mos B2 negative regulatory element inserted upstream of
the HIS3 gene expressed from a low activity minimal
promoter. The yeast strain YM4271 (his3,leu2) was
transformed with the reporter plasmid and transformants that expressed
low levels of HIS3 were selected for the ability to grow in
the absence of histidine but not in the presence of 30 mM
3-AT, which suppresses growth resulting from transcription from the
weak HIS3 promoter. A hybrid expression library consisting of HeLa cell cDNAs fused to the GAL4 activation domain was then screened to identify proteins that bound the c-mos B2
sequence and activated HIS3 transcription from the reporter
construct. The cDNA library vector also carried a LEU2
selectable marker, allowing selection of all transformants on
Leu medium and double selection of transformants in which
HIS3 expression was activated on
Leu /His /3-AT medium.
From an initial screen of approximately 6 million
LEU+ transformants, we isolated 200 colonies
that survived the double Leu /His /3-AT
selection. Plasmids recovered from these initial transformants were
then tested by retransformation of the reporter strain, and seven were
found to reproducibly induce HIS3 expression in this secondary screen. Nucleotide sequencing identified one of these 7 positive plasmids as COUP-TFI and three as COUP-TFII (22), indicating
that the COUP-TFs can bind to the c-mos B2 negative regulatory element. The specificity of this interaction is illustrated in Fig. 1. Transformation with plasmids
expressing either COUP-TFI or COUP-TFII fusion proteins allowed growth
of yeast carrying the c-mos/HIS3 reporter
construct on Leu /His /3-AT selective medium,
but not of yeast carrying a similar p53/HIS3 reporter
construct in which four copies of the binding site for p53 were
inserted upstream of HIS3. Conversely, an expression plasmid
for a p53/GAL4 fusion protein activated transcription from the
p53/HIS3 reporter construct but not from the
c-mos/HIS3 reporter. The transcription factors COUP-TFI and
COUP-TFII thus appeared to specifically recognize the 15-base pair
c-mos B2 negative regulatory element, activating
HIS3 transcription when expressed as GAL4 fusions in the
yeast one-hybrid system.

View larger version (94K):
[in this window]
[in a new window]
|
Fig. 1.
Specific activation of c-mos/HIS3
reporter constructs by plasmids encoding COUP-TF/GAL4 fusion
proteins. Yeast strains carrying either p53/HIS3 or
c-mos/HIS3 reporter constructs were transformed with a
control plasmid randomly picked from the HeLa cell cDNA/GAL4 fusion
library, with plasmids encoding COUP-TFI/or COUP-TFII/GAL4 fusion
proteins, or with a plasmid encoding a p53/GAL4 fusion protein.
Transformed yeast were plated either on Leu medium to
select all transformants or on Leu /His /3-AT
medium to select transformants in which expression of HIS3
was activated.
|
|
Binding of COUP Transcription Factors to the c-mos Negative
Regulatory Element in Electrophoretic Mobility Shift Assays--
The
COUP-TFs bind as homodimers to paired nuclear receptor hexamer-binding
sites (A/G)G(G/T)TCA (22, 25, 26) (Fig.
2). The highest affinity and most common
motif among identified COUP-TF regulatory site targets is a direct
repeat of the hexamer AGGTCA with single base pair spacing (DR1).
However, the COUP-TFs exhibit relatively promiscuous binding and
function on paired hexamers arranged as direct, inverted, or everted
repeats with different spacing (25), in contrast to other members of
the nuclear receptor superfamily whose functional specificity is
largely determined by hexamer spacing and orientation (21). Within the
c-mos B2 negative regulatory element, we identified a
candidate nuclear receptor hexamer-binding site AGTTCA. This is
separated by 1-base pair from a second inverted hexamer AGTACA, which
deviates from consensus by a single residue at the permissive fourth
position (Fig. 2). Based on the yeast one-hybrid results, this sequence appeared likely to represent a COUP-TF-binding site within the c-mos negative regulatory element. Consistent with this,
mutations of the c-mos negative regulatory element that had
previously been shown to abrogate binding of the candidate repressor
detected in somatic cell extracts and to allow expression of
c-mos promoter constructs in transfection assays in NIH 3T3
cells (mutants 7180, 7777, and 7777A) (17, 18) destroyed one or both of
these COUP-TF half-sites (Fig. 2).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 2.
COUP-TF-binding sites and mutations in the
c-mos B2 negative regulatory element. The
consensus COUP-TF-binding site DR1 consists of a direct repeat of the
half-site AAGTCA. The c-mos B2 element contains a candidate
inverted repeat COUP-TF-binding site shown in bold. This
site is altered in the c-mos mutants 7180, 7777, and 7777A
(altered nucleotides are underlined), which have previously been shown
to abrogate binding of the candidate repressor and allow expression
from the c-mos promoter in transfected NIH 3T3 cells (17,
18). NRRE-1 is an example of an everted repeat COUP-TF-binding site
(23). The sequences shown are those of the probes used in this
study.
|
|
To further characterize COUP-TF binding to the c-mos
regulatory sequence, we compared purified COUP-TFs with proteins
present in nuclear extracts of NIH 3T3 and HeLa cells in
electrophoretic mobility shift assays using both the c-mos
negative regulatory element and the previously defined COUP-TF-binding
sites DR1 and NRRE-1 (Fig. 2) as probes. The purified COUP-TFs formed
complexes of similar electrophoretic mobility with both the DR1 and
NRRE-1 COUP-TF-binding sites and with the c-mos negative
regulatory element B2 probe (Fig. 3). In
addition, nuclear extracts of both NIH 3T3 and HeLa cells formed
complexes of similar electrophoretic mobility with the c-mos
B2, DR1, and NRRE-1 probes. As expected, neither purified COUP-TFI nor
NIH 3T3 nuclear extract exhibited significant binding to a probe
consisting of only a single nuclear receptor half-site.

View larger version (71K):
[in this window]
[in a new window]
|
Fig. 3.
Binding of COUP-TFs to the c-mos
negative regulatory element in electrophoretic mobility shift
assays. Purified COUP-TFI and COUP-TFII were compared with whole
nuclear extracts of HeLa and NIH 3T3 cells for binding to probes of the
c-mos B2 element, the entire c-mos 111-base pair
negative regulatory region (411 probe), or of the established
COUP-TF-binding sites DR1 and NRRE-1. COUP-TF half-site probe was used
as a negative control. All protein-DNA complexes had indistinguishable
electrophoretic mobilities, although the free DNAs migrated
differently.
|
|
The specificity of COUP-TF binding to the c-mos negative
regulatory element was further tested by competition experiments (Fig.
4). Both purified COUP-TFII and nuclear
extract from NIH 3T3 cells formed similar complexes with B2 probe of
the c-mos negative regulatory element. In both cases,
binding was competed by an excess of unlabeled probe corresponding
either to the c-mos B2 sequence or to the DR1
COUP-TF-binding site. In contrast, binding was not affected by an
unrelated competitor corresponding to the binding site of a distinct
transcription factor, LSF (27). It is noteworthy that DR1 was a more
effective competitor than the c-mos B2 sequence for both
purified COUP-TFII and NIH 3T3 nuclear extract. This is consistent with
the higher affinities of COUP-TFs for the consensus DR1 elements as
opposed to inverted sequences, such as that present in the
c-mos B2 sequence (22, 25).

View larger version (91K):
[in this window]
[in a new window]
|
Fig. 4.
The DR1 consensus COUP-TF-binding site
competes for binding to the c-mos negative regulatory
element. Purified COUP-TFII and NIH 3T3 nuclear extract were
assayed for binding to a radiolabeled probe of the c-mos B2
element in electrophoretic mobility shift assays. Binding reactions
either contained no competitor (NONE), or 10- or 100-fold
excesses of unlabeled B2, DR1, or unrelated control probe corresponding
to the binding site of transcription factor LSF (27) as
competitors.
|
|
The results above not only indicate that COUP-TFs bind to the
c-mos B2 negative regulatory element, but also that COUP-TF complexes with the c-mos probe comigrate with complexes
formed with proteins detected in nuclear extracts of NIH 3T3 and HeLa cells. This is consistent not only with COUP-TFs being able to bind to
the c-mos negative regulatory element, but also with the hypothesis that COUP-TFs correspond to the candidate repressor previously identified in these somatic cell extracts. To further test
this hypothesis, we used antibody against COUP-TFs in supershift experiments (Fig. 5). Addition of COUP-TF
antibody (which recognizes both COUP-TFI and COUP-TFII) supershifted
the complex formed between nuclear extract of NIH 3T3 cells and probes
corresponding to either the 15-base pair B2 element of the
c-mos negative regulatory sequence or to the entire 111-base
pair c-mos negative regulatory sequence (411 probe)
originally defined by deletion analysis (17). As expected, no protein
binding was detected to a 111-base pair c-mos probe
containing the 7180 mutation, which destroys the COUP-TF-binding site
(see Fig. 2). Antibody against COUP-TF thus recognizes the c-mos negative regulatory element-binding protein detected
in somatic cell nuclear extracts, identifying this candidate repressor of c-mos transcription as COUP-TF.

View larger version (66K):
[in this window]
[in a new window]
|
Fig. 5.
Antibody to COUP-TF recognizes the
c-mos B2 element-binding protein in NIH 3T3 nuclear
extracts. Nuclear extracts of NIH 3T3 cells were incubated with
c-mos B2 probe, with a probe containing 3 tandem repeats of
the B2 sequence (3XB2), with c-mos 411 probe
(consisting of the entire 111-base pair c-mos negative
regulatory region), or with c-mos 411 probe containing the
7180 mutation (see Fig. 2). Nuclear extracts were preincubated for 30 min with antibody against COUP-TFs in the lanes designated +Ab.
Lane 1 is a reaction in which B2 probe was incubated with antibody
in the absence of nuclear extract.
|
|
COUP-TF-binding Sites Function as Negative Regulatory Elements of
the c-mos Promoter--
Previous studies defined three functional
elements (designated B1, B2, and B3) within the 111-base pair
c-mos negative regulatory region (17). Mutations affecting
the previously defined B2 element destroy one or both of the consensus
nuclear receptor-binding sites (see Fig. 2) and allow expression of
c-mos promoter/CAT constructs in transfection assays in NIH
3T3 cells (17, 18), indicating that the COUP-TF-binding site is one of
the functional elements within the c-mos negative regulatory sequence.
To further determine whether a consensus COUP-TF-binding site can
functionally replace the B2 negative regulatory element, we
investigated the activity of c-mos promoter constructs in
which a consensus DR1 COUP-TF-binding site was substituted for the
normal c-mos negative regulatory sequences (Fig.
6). In these experiments, the entire
c-mos negative regulatory region (including B1, B2, and B3
sequences) was deleted in the c-mos/ 392 construct, and replaced with a consensus DR1 COUP-TF-binding site in the
c-mos/ 380/DR1 plasmid. Addition of a COUP-TF-binding site
to this truncated promoter in the c-mos/ 380/DR1 construct
resulted in a 2-3-fold reduction in CAT expression, to a level about
twice that obtained with the full-length c-mos/ 746
promoter. The complete negative regulatory sequence contained within
the c-mos/ 746 construct includes the B1 and B3 elements in
addition to B2, and the partial repression obtained with the
c-mos/ 380/DR1 construct is similar to that seen with other
constructs containing only the B2 element (17). It thus appears that a
consensus COUP-TF-binding site can functionally substitute for the
c-mos B2 negative regulatory element, further indicating
that COUP-TF can repress c-mos transcription in transfected
somatic cells.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of a consensus COUP-TF-binding site on
transcriptional activity of the c-mos promoter.
NIH 3T3 cells were transfected with the indicated c-mos/CAT
constructs and harvested 48 h post-transfection for assays of CAT
activity. The c-mos/CAT constructs contained upstream
c-mos sequences extending to either 746 (including the
entire negative regulatory region) or to 392 (from which the negative
regulatory region has been deleted). A DR1 consensus COUP-TF-binding
site has been added in place of the c-mos negative
regulatory region in the plasmid designated 380/DR1. The results of
five independent transfection assays are presented individually in
panel A, with CAT activities expressed relative to the
c-mos/ 746 construct, and as mean ± S.D. in
panel B. The difference in activities of the 392 and
380/DR1 constructs was statistically significant (p < 0.001).
|
|
 |
DISCUSSION |
The specific expression of the c-mos proto-oncogene in
male and female germ cells provides a novel example of tissue-specific transcriptional regulation. Because aberrant expression of
c-mos in somatic cells results in either oncogenic
transformation or cell death (15, 28, 29), the normal transcriptional
silencing of c-mos is a critical aspect of its control.
Previous studies delineated 3 negative regulatory elements (designated
B1, B2, and B3) within a 111-base pair region upstream of the
c-mos spermatocyte promoter (17) and identified a candidate
repressor that bound to the B2 element, suppressing c-mos
transcription in somatic cells (18). In the present study, we have
identified this somatic cell repressor of c-mos
transcription as the orphan nuclear receptor COUP-TF.
Mice and humans encode two closely related members of the COUP-TF
family, designated COUP-TFI and COUP-TFII (22). We initially isolated
clones of both COUP-TFI and COUP-TFII, which have indistinguishable DNA-binding specificities (22), in a yeast one-hybrid screen for
proteins that bound to the c-mos B2 negative regulatory
element. A COUP-TF-binding site was then identified within this
element. Notably, the complexes formed between purified COUP-TFs and
the c-mos B2 probe in electrophoretic mobility shift assays
comigrated with those formed using whole nuclear extracts of NIH 3T3 or
HeLa cells, suggesting that COUP-TF was the candidate repressor
previously detected in extracts of these somatic cells (18). The
identity of the candidate repressor previously detected in NIH 3T3 and HeLa cells as COUP-TF was then established by demonstrating that antibody against COUP-TFs supershifted the complex formed between the
c-mos B2 probe and NIH 3T3 or HeLa cell nuclear extracts. Consistent with the role of COUP-TF as a transcriptional repressor, mutations of the B2 element that destroyed the COUP-TF-binding site
allowed expression from the c-mos promoter in transfected somatic cells (17, 18). Conversely, substitution of a consensus COUP-TF-binding site in place of the c-mos negative
regulatory element suppressed expression from the c-mos
promoter. It thus appears that COUP-TF can bind to one of the negative
regulatory elements of the c-mos promoter and contribute to
repression of c-mos transcription in somatic cells.
Additional proteins that bind to the B1 and B3 elements of the
c-mos negative regulatory region (17) as well as the
Cux/CDP homeodomain protein, which binds to an enhancer in
the rat c-mos locus (30), may also contribute to repression
of c-mos in somatic cells.
The identification of COUP-TFs as somatic cell repressors of
c-mos is consistent with several known properties of these
proteins. COUP-TFI and COUP-TFII are closely related proteins that bind DNA as homodimers and repress transcription of a variety of target genes (21, 22, 31). In addition, the COUP-TFs can form heterodimers with the common nuclear receptor partner protein retinoid X receptor, thereby indirectly modulating the activities of other members of the
nuclear receptor family, such as retinoic acid receptors and thyroid
hormone receptors (22). Both COUP-TFI and COUP-TFII are expressed in a
wide variety of mouse cells and tissues (22, 32, 33), consistent with
the general repression of c-mos in somatic cells.
Inactivation of the genes encoding COUP-TFI or COUP-TFII leads to
perinatal or early embryonic death, respectively, indicating that the
two COUP-TFs have essential nonredundant roles in early development
(22, 34). However, the physiologically critical target genes regulated
by COUP-TFs have not been identified. Given the lethal consequences of
unregulated c-mos expression, repression of c-mos
may be one of these critical functions of COUP-TFs.
Although COUP-TFs were the only nuclear receptors detected in our yeast
one-hybrid screen of HeLa cell cDNAs, the identification of a
COUP-TF-binding site in the c-mos promoter raises the
possibility that other members of the nuclear receptor superfamily may
also recognize this element. In this regard, it is noteworthy that another member of the nuclear receptor superfamily, germ cell nuclear
factor (GCNF), is specifically expressed in the germ cells of male and
female adult mice (35-37). GCNF has therefore been suggested to
function in germ cell development by regulating the expression of germ
cell-specific genes, and the mouse protamine genes have been identified
as candidate GCNF targets (38). GCNF shares a DNA-binding domain P box
structure with COUP-TF, dictating binding to similar hexamer sequences.
Although the recognized GCNF targets have DR0 type motifs, it is
possible that this factor also binds the c-mos B2 element.
If this is the case, GCNF may play a positive role in activating
c-mos expression in germ cells, while COUP-TF represses
c-mos in somatic cells.
 |
ACKNOWLEDGEMENT |
We are grateful to Ming-Jer Tsai for antibody
against COUP-TFs.
 |
FOOTNOTES |
*
This work was supported by Grants RO1-HD26594, RO1-HD35685,
and KO2-DK02461 from the National Institutes of Health and a fellowship from the Deutsche Akademie der Naturforscher Leopoldina (to M. J.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of Biology,
Boston University, 5 Cummington St., Boston, MA 02215. Tel.: 617-353-8735; Fax: 617-353-8484; E-mail: gmcooper@bu.edu.
 |
ABBREVIATIONS |
The abbreviations used are:
3-AT, 3-amino-1,2,4-triazole;
CAT, chloramphenicol acetyltransferase;
GCNF, germ cell nuclear factor.
 |
REFERENCES |
| 1.
|
Goldman, D. S.,
Kiessling, A. A.,
Millette, C. F.,
and Cooper, G. M.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
4509-4513[Abstract/Free Full Text]
|
| 2.
|
Mutter, G. L.,
and Wolgemuth, D. J.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
5301-5305[Abstract/Free Full Text]
|
| 3.
|
Pal, S. K.,
Torry, D.,
Serta, R.,
Crowell, R. C.,
Seibel, M. M.,
Cooper, G. M.,
and Kiessling, A. A.
(1994)
Fertil. Steril.
61,
496-503[Medline]
[Order article via Infotrieve]
|
| 4.
|
Paules, R. S.,
Propst, F.,
Dunn, K. J.,
Blair, D. G.,
Kaul, K.,
Palmer, A. E.,
and Vande Woude, G. F.
(1988)
Oncogene
3,
59-68
|
| 5.
|
Propst, F.,
Rosenberg, M. P.,
Iyer, A.,
Kaul, K.,
and Vande Woude, G. F.
(1987)
Mol. Cell. Biol.
7,
1629-1637[Abstract/Free Full Text]
|
| 6.
|
Propst, F.,
and Vande Woude, G. F.
(1985)
Nature
315,
516-518[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Schmidt, M.,
Oskarsson, M. K.,
Dunn, K. J.,
Blair, D. G.,
Hughes, S.,
Propst, F.,
and Vande Woude, G. F.
(1988)
Mol. Cell. Biol.
8,
923-929[Abstract/Free Full Text]
|
| 8.
|
Van der Hoorn, F. A.,
Spiegel, J. E.,
Maylie-Pfenninger, M. F.,
and Nordeen, S. K.
(1991)
Oncogene
6,
929-932[Medline]
[Order article via Infotrieve]
|
| 9.
|
Colledge, W. H.,
Carlton, M. B. L.,
Udy, G. B.,
and Evans, M. J.
(1994)
Nature
370,
65-68[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Hashimoto, N.,
Watanabe, N.,
Furuta, Y.,
Tamemoto, H.,
Sagata, N.,
Yokoyama, M.,
Okazaki, K.,
Nagayoshi, M.,
Takeda, N.,
Ikawa, Y.,
and Aizawa, S.
(1994)
Nature
370,
68-71[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Kanki, J. P.,
and Donoghue, D. J.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
5794-5798[Abstract/Free Full Text]
|
| 12.
|
O'Keefe, S. J.,
Wolfes, H.,
Kiessling, A. A.,
and Cooper, G. M.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
7038-7042[Abstract/Free Full Text]
|
| 13.
|
Sagata, N.,
Oskarsson, M.,
Copeland, T.,
Brumbaugh, J.,
and Vande Woude, G. F.
(1988)
Nature
335,
519-525[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Sagata, N.,
Watanabe, N.,
Vande Woude, G. F.,
and Ikawa, Y.
(1989)
Nature
342,
512-518[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Sagata, N.
(1997)
BioEssays
19,
13-21[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Pal, S. K.,
Zinkel, S. S.,
Kiessling, A. A.,
and Cooper, G. M.
(1991)
Mol. Cell. Biol.
11,
5190-5196[Abstract/Free Full Text]
|
| 17.
|
Zinkel, S. S.,
Pal, S. K.,
Szeberenyi, J.,
and Cooper, G. M.
(1992)
Mol. Cell. Biol.
12,
2029-2036[Abstract/Free Full Text]
|
| 18.
|
Xu, W.,
and Cooper, G. M.
(1995)
Mol. Cell. Biol.
15,
5369-5375[Abstract]
|
| 19.
|
Wang, M. M.,
and Reed, R. R.
(1993)
Nature
364,
121-126[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Li, J. J.,
and Herskowitz, I.
(1993)
Science
262,
1870-1874[Abstract/Free Full Text]
|
| 21.
|
Mangelsdorf, D. J.,
and Evans, R. M.
(1995)
Cell
83,
841-850[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Tsai, S. Y.,
and Tsai, M.-J.
(1997)
Endocr. Rev.
18,
229-240[Abstract/Free Full Text]
|
| 23.
|
Carter, M. E.,
Gulick, T.,
Moore, D. D.,
and Kelly, D. P.
(1994)
Mol. Cell. Biol.
14,
4360-4372[Abstract/Free Full Text]
|
| 24.
|
Wang, L.-H.,
Tsai, S. Y.,
Cook, R. G.,
Beattie, W. G.,
Tsai, M.-J.,
and O'Malley, B. W.
(1989)
Nature
340,
163-166[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Cooney, A. J.,
Tsai, S. Y.,
O'Malley, B. W.,
and Tsai, M.-J.
(1992)
Mol. Cell. Biol.
12,
4153-4163[Abstract/Free Full Text]
|
| 26.
|
Nakshatri, H.,
and Chambon, P.
(1994)
J. Biol. Chem.
269,
890-902[Abstract/Free Full Text]
|
| 27.
|
Huang, H.-C.,
Sundseth, R.,
and Hansen, U.
(1990)
Genes Dev.
4,
287-298[Abstract/Free Full Text]
|
| 28.
|
Papkoff, J.,
Verma, I. M.,
and Hunter, T.
(1982)
Cell
29,
417-426[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Oskarsson, M.,
McClements, W. L.,
Blair, D. G.,
Maizel, J. V.,
and Vande Woude, G. F.
(1980)
Science
207,
1222-1224[Abstract/Free Full Text]
|
| 30.
|
Higgy, N. A.,
Tarnasky, H. A.,
Valarche, I.,
Nepveu, A.,
and Van der Hoorn, F. A.
(1997)
Biochim. Biophys. Acta
1351,
313-324[Medline]
[Order article via Infotrieve]
|
| 31.
|
Shibata, H.,
Nawaz, Z.,
Tsai, S. Y.,
O'Malley, B. W.,
and Tsai, M.-J.
(1997)
Mol. Endocrinol.
11,
714-724[Abstract/Free Full Text]
|
| 32.
|
Pereira, F. A.,
Qiu, Y.,
Tsai, M.-J.,
and Tsai, S. Y.
(1995)
J. Steroid Biochem. Mol. Biol.
53,
503-508[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Jonk, L. J. C.,
de Jonge, M. E. J.,
Pals, C. E. G. M.,
Wissink, S.,
Vervaart, J. M. A.,
Schoorlemmer, J.,
and Kruijer, W.
(1994)
Mech. Devel.
47,
81-97[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Qiu, Y.,
Pereira, F. A.,
DeMayo, F. J.,
Lydon, J. P.,
Tsai, S. Y.,
and Tsai, M.-J.
(1997)
Genes Dev.
11,
1925-1937[Abstract/Free Full Text]
|
| 35.
|
Bauer, U.-M.,
Schneider-Hirsch, S.,
Reinhardt, S.,
Benavente, R.,
and Maelicke, A.
(1998)
FEBS Lett.
208,
208-214
|
| 36.
|
Chen, F.,
Cooney, A. J.,
Wang, Y.,
Law, S. W.,
and O'Malley, B. W.
(1994)
Mol. Endocrinol.
8,
1434-1444[Abstract/Free Full Text]
|
| 37.
|
Katz, D.,
Niederberger, C.,
Slaughter, G. R.,
and Cooney, A. J.
(1997)
Endocrinology
138,
4364-4372[Abstract/Free Full Text]
|
| 38.
|
Hummelke, G. C.,
Meistrich, M. L.,
and Cooney, A. J.
(1998)
Mol. Repro. Dev.
50,
396-405[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. M. Kehoe, M. Oka, K. E. Hankowski, N. Reichert, S. Garcia, J. R. McCarrey, S. Gaubatz, and N. Terada
A Conserved E2F6-Binding Element in Murine Meiosis-Specific Gene Promoters
Biol Reprod,
November 1, 2008;
79(5):
921 - 930.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Rodic, M. Oka, T. Hamazaki, M. R. Murawski, M. Jorgensen, D. M. Maatouk, J. L. Resnick, E. Li, and N. Terada
DNA Methylation Is Required for Silencing of Ant4, an Adenine Nucleotide Translocase Selectively Expressed in Mouse Embryonic Stem Cells and Germ Cells
Stem Cells,
September 1, 2005;
23(9):
1314 - 1323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Guo, J. Lynch, K. Nakamura, L. Fliegel, H. Kasahara, S. Izumo, I. Komuro, L. B. Agellon, and M. Michalak
COUP-TF1 Antagonizes Nkx2.5-mediated Activation of the Calreticulin Gene during Cardiac Development
J. Biol. Chem.,
January 19, 2001;
276(4):
2797 - 2801.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|